To determine whether the presence of endocrine resistance markers has a causal impact on estrogen response markers, we assessed the effect of endocrine-resistant gene (ERBB2, BCL2, and CCND1) inhibitors on estrogen response markers in FA organoids. This evidence concerns the gene BCL2 and Friedreich ataxia.